I don't know if anyone is still on this board but I would like to see a response to a lengthy comment by aeroval on the Yahoo board to someone who suggested that we should hold the stock at least through December:
The stretching of your time line indicates to me you must be an employee of ARNX. This was intended to be a buy and hold value play for me, but the value is rapidly diminishing. After almost 3 years, and two regimes, ARNX is still dickering with a corp. partner for Nyotran. The company has given me ABSOLUTELY NOTHING to hang my hat on and hold this stock.
I'll say it again, either this shit is real good, or ARNX is being greedy and stupid over nothing. Time will tell. By the time Nyotran gets to the market, I'll be dead. Early in 98, Cox indicated that ARNX didn't expect to go to the street for more money before becoming profitable. I see the sentiment now shifting negative with tax loss selling approaching. I've got news, ARNX will be one of the first to
go when that time comes. You say wait til December, for what?? Maybe
there is a valid reason as to why Chubb couldn't get a deal done. More
like no one wants it. I promise I won't wait til DECEMBER to find out.
I suggest a conference call with analysts and investors, very soon to update the progress of Nyotran with specifics, or a deal announcement.
The market seems to have yawned at the recent insider activity.
I own alot of shares, and I wouldn't consider buy another share until
after I see the Nyotran deal.
This deal has been stretched out so long and the stock price has deprecitated so much that I am concerned that most investors will use Nyotran (if it happens), as an exit to this story, thus not adding much value to stock price.
How can ARNX expect more coverage from analysts/brokerage houses with
this dissappointing story.
Remember, I'm a considerable sized investor.... I worry about the institutional investors, 100K plus shares, in @ 7-10$, that are becoming tired and seeing the reality as out of reach. |
